Skip to main content
Advertisement
PLOS statement on recent US Executive Orders

February 21, 2025

PLOS statement on recent US Executive Orders

PLOS remains committed to the principle of open science: integrity, transparency, inclusivity, and collaboration.

Please read more on our blog.

Image credit: PLOS

Calling all experts!

PLOS Pathogens welcomes talented individuals to join our editorial board. 

Apply now

05/16/2025

pearls

Fast and flu-rious: How to prevent and treat emerging influenza A viruses

This article explores influenza A virus, a highly adaptable zoonotic pathogen behind seasonal flu and pandemics. It examines the biological mechanisms that enable IAV to cross species barriers and evolve rapidly, particularly through mutation and reassortment, making it difficult to control. The authors assess current prevention and treatment strategies, highlight emerging threats and outline recent technological and scientific advances to improve pandemic preparedness.

Image credit: ppat.1013135

Fast and flu-rious: How to prevent and treat emerging influenza A viruses

Recently Published Articles

Current Issue

Current Issue April 2025

05/12/2025

review

TRIM proteins: A ‘swiss army knife’ of antiviral immunity

With their modular structure and E3 ubiquitin ligase activity, Tripartite motif proteins interact with a range of cellular and viral substrates. This review highlights their role in the antiviral response and details the two complementary modes of regulation by TRIM proteins: their indirect antiviral actions, mediated through various cellular pathways, and their direct effects on the viral life cycle. It also examines viral strategies emerging from the co-evolution between viruses and TRIMs.

Image credit: ppat.1013147

TRIM proteins: A ‘swiss army knife’ of antiviral immunity

05/07/2025

pearls

Candida auris is emerging as a prevalent urinary pathogen

C. auris has rapidly emerged as a clinically significant pathogen due to its antifungal resistance, high mortality rates, and limited understanding around its prevalence and pathophysiology. To understand whether C. auris is prevalent in the urinary tract, here the authors analyzed 12,996 C. auris clinical strains, identifying urine as the second most common C. auris isolation source in the United States and the third most common worldwide.

Image credit: ppat.1013138

Candida auris is emerging as a prevalent urinary pathogen

Get new content from PLOS Pathogens in your inbox

PLOS Pathogens | ISSN: 1553-7374 (online)